Histone deacetylases and cancer-associated angiogenesis: current understanding of the biology and clinical perspectives

Critical Reviews in Oncogenesis
Andrei TurtoiAkeila Bellahcène

Abstract

Histone deacetylase enzymes (HDACs) have been shown to be important to the development and progression of human cancers. Angiogenesis is a vital process that facilitates tumor growth and survival. More than a dozen of different activators and inhibitors are involved in at least as many diverse mechanisms to control angiogenesis. HDACs directly or indirectly control many of these regulators. In the current review, we give a brief overview of molecular mechanisms of HDAC actions and link these to the current knowledge concerning HDAC-mediated regulation of tumor-associated angiogenesis. HDAC specific knockdown studies and the use of pan-HDAC inhibitors (HDACi) contributed to the identification of: (i) HDACs that are key to angiogenesis and (ii) their multiple protein targets essential for angiogenic process. The clinical development of HDACi is an active area of investigation. In the scope of this review, we highlight several preclinical studies that examine the anti-angiogenic role of HDACi. Certainly, there is still much to be learned about the use of HDACi to inhibit tumoral angiogenesis. Recent efforts in the clinics aiming to combine broad HDACi (mainly vorinostat, which is FDA approved for T-cell lymphoma) with other anti-a...Continue Reading

Citations

Sep 24, 2015·Future Medicinal Chemistry·Peter J Brown, Susanne Müller
Jul 10, 2019·Scientific Reports·Xiaohua LiShikun He
Nov 4, 2017·Epigenetics : Official Journal of the DNA Methylation Society·Katrina V GoodJuan Ausió
Apr 26, 2021·Drug Discovery Today·Ganji Purnachandra NagarajuSarfraz Ahmad
Jan 15, 2017·The American Journal of Pathology·Laurent EhrlichShannon Glaser

❮ Previous
Next ❯

Related Concepts

Related Feeds

Angiogenesis Inhibitors to Treat Cancer

Cancer treatments including angiogenesis inhibitors prevent tumor cells from receiving nutrients and oxygen. Here is the latest research on angiogenesis inhibitors for the treatment of cancer.